Method Article

Application of Laparoscopic Programmatic Neurolymphatic Radical Pancreaticoduodenectomy in Pancreatic Head Cancer

DOI:

10.3791/68272

⸱

September 2nd, 2025

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This protocol introduces Laparoscopic Programmatic Neurolymphatic Radical Pancreaticoduodenectomy (LPNRPD), a standardized surgical approach for pancreatic head cancer, emphasizing safety, reproducibility, and effective R0 resection through modular techniques and radical neurolymphatic dissection.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Laparoscopic pancreaticoduodenectomy (LPD) has become a widely adopted surgical approach for treating pancreatic head cancer. Traditional open pancreaticoduodenectomy (OPD) is associated with significant surgical trauma, with postoperative hospital stays often exceeding 2 weeks. In contrast, LPD presents higher surgical risks due to the lack of standardized protocols, particularly posing challenges in minimally invasive resection and anastomosis. In addition, the optimal extent of lymphatic and neural dissection in pancreatic head cancer remains controversial and continues to be actively debated. To address these challenges in traditional pancreatic cancer treatment, we developed a modular surgical approach and a dual-surgeon model to systematize laparoscopic pancreatic surgery. Our novel Laparoscopic Programmatic Neurolymphatic Radical Pancreaticoduodenectomy (LPNRPD) technique not only ensures surgical safety but is also user-friendly, making it particularly suitable for laparoscopic surgery beginners. For radical resection of pancreatic head cancer, we propose that complete dissection of the peripancreatic neural plexus is critical for achieving R0 resection. Through multicenter RCT studies, we established standardized protocols for radical neurolymphatic dissection tailored to different subtypes of pancreatic cancer. For patients with resectable pancreatic head cancer (preoperative CA19-9 < 200 U/mL, no vascular invasion), we recommend the LPNRPD strategy. However, the successful implementation of LPNRPD heavily relies on the surgeon's skill and expertise. This article provides a comprehensive overview of the techniques for performing LPNRPD, emphasizing its safety, reproducibility, and applicability in the context of pancreatic head cancer treatment.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Pancreatic cancer, known as the king of cancer, is marked by late detection, low resectability, and poor prognosis. Surgical resection remains the only potentially curative treatment and a critical first step. Despite advancements in multidisciplinary strategies, the 5-year survival rate after R0 resection remains unsatisfactory, highlighting the need for improved therapies1.

Perineural invasion (PNI), marked by tumor infiltration and spread along nerves, is a key driver of early progression, recurrence, and poor prognosis in cancer patients2,3. With an incid....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This study included 76 patients who underwent LPNRPD between August 2019 and January 2022. The protocol received approval from the Institutional Review Board of Guangdong Provincial People's Hospital, and all participants provided written informed consent. The Table of Materials provides details of the consumables and equipment used.

1. Inclusion criteria

  1. Include patients with pancreatic head carcinoma, including ductal adenocarcinoma (64 cases), adenosquamous carcinoma (11 cases), and colloid carcinoma (1 case).
  2. Include patients with tumor involvement of the CA, SMA, or abdominal ....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Baseline and intraoperative data (Table 1)
From January 2018 to January 2022, a total of 76 cases of LPNRPD were performed. The conversion rate to open surgery was 10.5%, and the rate of laparoscopic venous reconstruction was 5.3%. The proportion of preoperative biliary drainage was 39.4%. The median operative time was 250 min (135-425 min), median intraoperative blood loss was 50 mL (20-1500 mL), and the rate of intraoperative red blood cell transfusion was 13.2%.

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Current expert consensus, both domestically and internationally, recommends performing LPD in high-volume pancreatic minimally invasive surgery centers20. As surgical experience accumulates, the learning curve for LPD has progressively shortened. An analysis by Adam's team at Duke University, based on 865 LPD cases in the United States from 2000 to 2012, showed that performing more than 22 LPDs annually significantly reduces postoperative complications18. Updated data f.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This work was supported by grants from the National Natural Science Foundation of China (grant numbers 82372858), the Guangzhou Science and Technology Bureau Basic and Applied Research Project (grant numbers 2025A04J4765), the Major Clinical Technology Projects in Guangzhou(grant numbers 2023P-ZD08).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
4-0 Prolene *5 strands8521None
4-0 Prolene *5 strandsW8557None
5-0 PDS suture *2 strandsPDP148None
5-0 Prolene *5 strandsW8310/EPH8710None
0 Absorbable suture *1 strandVCP752DNone
3-0 (15 cm) V-LOC suture *1 strandLOCL0614None
4-0 (7x7 cm) Absorbable suture *1 strandVCP771DNone
5-0 Prolene *5 strandsEPH8710?W8310/W8710None
5-0 *3 strandsPDP148None
4-0 Prolene *2 strandsHS6855None
Titanium clips *3 packagesNone
Trocars (12mm) *5None
Ultracision Harmonic Curved Scissors *1HAR36CNNone
Straight cut closure *1PSEE60ANone
60mm blue and white nails for cutting closure device *2 (each)ECR60BNone
Multifunctional Abdominal Drainage Tubes *1 (each)M8A/M10ANone
Hem-o-lok Green Clips *20 packagesNone
Hem-o-lok Purple Clips *10 packagesNone
Hem-o-lok Brown Clips *5 packagesNone
4K3D FluoroscopyNone
Bipolar Electrocoagulation ClampNone
Ultrasonic Scalpel HandleNone

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Palmer, D. H., et al. Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial. J Clin Oncol. , (2024).
  2. Zheng, S., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Laparoscopic PancreaticoduodenectomyPancreatic Head CancerNeurolymphatic DissectionRadical PancreaticoduodenectomyMinimally Invasive SurgeryPeripancreatic Neural PlexusDual Surgeon ModelSurgical StandardizationR0 ResectionLymphatic Dissection
Video Coming Soon

Related Articles